Tag: Phase 2/3 trials

Phase 2/3 trials of Covovax in children aged 7 to 11 begins in Pune

Covovax is the Indian version of the Novovax vaccine brought in India by the Serum Institute of India for children.

October 1, 2021

Biological E gets DCGI nod to conduct phase 2/3 trials on children

The trial will be on children between 5 and 18 years of age with certain conditions and conducted in 10 locations across the country,

September 2, 2021